Nathan A. Pennell/LinkedIn
Apr 7, 2025, 19:22
Nathan A. Pennell: Excited to have played a part in this exciting drug’s development
Nathan A. Pennell, Editor in Chief at American Society of Clinical Oncology (ASCO), shared on X about a recent paper by Maurice Pérol et al. published in Journal of Clinical Oncology:
“Excited to have played a part in this exciting drug’s development, hopefully soon will be available for patients!
Taletrectinib in ROS1+ Non–Small Cell Lung Cancer: TRUST | Journal of Clinical Oncology”
Authors: Maurice Pérol et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 21, 2025, 13:44
May 21, 2025, 13:43
May 21, 2025, 13:32
May 21, 2025, 13:04